Correlation Between Vertex Pharmaceuticals and PROSIEBENSAT1 MEDIADR4/

Can any of the company-specific risk be diversified away by investing in both Vertex Pharmaceuticals and PROSIEBENSAT1 MEDIADR4/ at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vertex Pharmaceuticals and PROSIEBENSAT1 MEDIADR4/ into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vertex Pharmaceuticals Incorporated and PROSIEBENSAT1 MEDIADR4, you can compare the effects of market volatilities on Vertex Pharmaceuticals and PROSIEBENSAT1 MEDIADR4/ and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vertex Pharmaceuticals with a short position of PROSIEBENSAT1 MEDIADR4/. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vertex Pharmaceuticals and PROSIEBENSAT1 MEDIADR4/.

Diversification Opportunities for Vertex Pharmaceuticals and PROSIEBENSAT1 MEDIADR4/

-0.26

Correlation Coefficient

Vertex Pharmaceuticals  PROSIEBENSAT1 MEDIADR4/

Very good diversification

The 3 months correlation between Vertex and PROSIEBENSAT1 is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Vertex Pharmaceuticals Incorpo and PROSIEBENSAT1 MEDIADR4 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PROSIEBENSAT1 MEDIADR4/ and Vertex Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vertex Pharmaceuticals Incorporated are associated (or correlated) with PROSIEBENSAT1 MEDIADR4/. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PROSIEBENSAT1 MEDIADR4/ has no effect on the direction of Vertex Pharmaceuticals i.e., Vertex Pharmaceuticals and PROSIEBENSAT1 MEDIADR4/ go up and down completely randomly.

Pair Corralation between Vertex Pharmaceuticals and PROSIEBENSAT1 MEDIADR4/

Assuming the 90 days horizon Vertex Pharmaceuticals Incorporated is expected to generate 0.95 times more return on investment than PROSIEBENSAT1 MEDIADR4/. However, Vertex Pharmaceuticals Incorporated is 1.05 times less risky than PROSIEBENSAT1 MEDIADR4/. It trades about -0.05 of its potential returns per unit of risk. PROSIEBENSAT1 MEDIADR4 is currently generating about -0.06 per unit of risk. If you would invest  41,215  in Vertex Pharmaceuticals Incorporated on September 25, 2024 and sell it today you would lose (3,715) from holding Vertex Pharmaceuticals Incorporated or give up 9.01% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.46%
Values	Daily Returns

Vertex Pharmaceuticals Incorpo  vs.  PROSIEBENSAT1 MEDIADR4

Vertex Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Vertex Pharmaceuticals Incorporated has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

PROSIEBENSAT1 MEDIADR4/

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days PROSIEBENSAT1 MEDIADR4 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's primary indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Pair Trading with Vertex Pharmaceuticals and PROSIEBENSAT1 MEDIADR4/

The main advantage of trading using opposite Vertex Pharmaceuticals and PROSIEBENSAT1 MEDIADR4/ positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vertex Pharmaceuticals position performs unexpectedly, PROSIEBENSAT1 MEDIADR4/ can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PROSIEBENSAT1 MEDIADR4/ will offset losses from the drop in PROSIEBENSAT1 MEDIADR4/'s long position.

The idea behind Vertex Pharmaceuticals Incorporated and PROSIEBENSAT1 MEDIADR4 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.